94% of all revenue goes towards our programs, with only 6% towards MANAGEMENT AND GENERAL EXPENSES.
African-American Patient Guide
James Abbruzzese, MD Chief, Medical Oncology Duke University
Markus Büchler, MD Chairman, Surgery Heidelberg University, Germany
Ralph Hruban, MD Director, GI / Liver Pathology Johns Hopkins University
Eileen O’Reilly, MD Associate Director for Clinical Research – Memorial Sloan-Kettering Cancer Center
Margaret Tempero, MD Chief, Medical Oncology University of California at San Francisco
Written by: Jasmine Mitchell, University of California Santa Barbara
Edited by: Dale O’Brien, MD, Cancer Patients Alliance
Formatting and content by: Raewyn O’Haire, AB, Cancer Patients Alliance
Consultant: Neil Atam, University of California Santa Barbara
Pancreatic cancer is a serious disease. Taking an aggressive rational stance at the earliest possible time, supported by the best medical team, and treated in the most appropriate manner gives the best chance for survival.
We believe in strong patient-physician bonds, scientifically-based treatment, and that comfort can come from knowing that everything that reasonably can be done – is being done.
That the best approach is meeting cancer of the pancreas head-on and armed with the best available information.